Literature DB >> 20203135

Biological safety of neutral-pH hydrogen-enriched electrolyzed water upon mutagenicity, genotoxicity and subchronic oral toxicity.

Yasukazu Saitoh1, Yoshikazu Harata, Fukutaro Mizuhashi, Madoka Nakajima, Nobuhiko Miwa.   

Abstract

Hydrogen-dissolved water has been suggested to be effective for alleviating the oxidative stress. In the present study, neutral-pH hydrogen-enriched electrolyzed water (NHE-water; dissolved hydrogen: 0.90-1.14 parts per million [ppm]; oxido-reduced potential: -150 approximately -80 mV), which was prepared with a water-electrolysis apparatus equipped with a non-diaphragm cell and a highly compressed activated-carbon block, was evaluated for the mutagenic and genotoxic potentials, at concentrations up to 100% dose/plate, and for the subchronic toxicity. NHE-water did not induce reverse mutations in Salmonella typhimurium strains TA100, TA1535, TA98 and TA1537, and Escherichia coli strain WP2uvrA, in either the absence or presence of rat liver S9 for exogenous metabolic activation. Similarly, NHE-water did not induce chromosome aberrations in Chinese hamster lung fibroblast cells (CHL/IU), in short-term (6-hour) tests, with or without rat liver S9, or in a continuous treatment (24-hour) test. To evaluate the subchronic toxicity, Crj:CD(SD) specific pathogen free (SPF)-rats were administered with NHE-water at a dose of 20 mL/kg/day for 28 days via intragastric infusion. NHE-water-related toxic changes were not seen in terms of any items such as clinical symptoms, body weight, food consumption, urinalysis, hematology, blood chemistry, necropsy, each organ weight and histopathology. Thus, the no-observable-adverse-effect level (NOAEL) for NHE-water was estimated to be greater than 20 mL/kg/day under the conditions examined, demonstrating the consistency with the expected safety for a human with a body weight of 60 kg to drink the NHE-water up to at least 1.2 L/day.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203135     DOI: 10.1177/0748233710362989

Source DB:  PubMed          Journal:  Toxicol Ind Health        ISSN: 0748-2337            Impact factor:   2.273


  20 in total

1.  Protective effects of dissolved molecular hydrogen against hydrogen peroxide-, hydroperoxide-, and glyoxal-induced injuries to human skin keratinocytes.

Authors:  Yasukazu Saitoh; Yuuki Yamaguchi; Yuhei Okada
Journal:  Mol Cell Biochem       Date:  2021-05-24       Impact factor: 3.396

2.  Hydrogen inhalation protects hypoxic-ischemic brain damage by attenuating inflammation and apoptosis in neonatal rats.

Authors:  Guojiao Wu; Zhiheng Chen; Peipei Wang; Mingyi Zhao; Masayuki Fujino; Chen Zhang; Wenjuan Zhou; Shin-Ichi Hirano; Xiao-Kang Li; Lingling Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-12

Review 3.  Hydrogen treatment: a novel option in liver diseases.

Authors:  Jian Shi; Brittany Duncan; Xuyuan Kuang
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

4.  Molecular hydrogen suppresses Porphyromonas gingivalis lipopolysaccharide-induced increases in interleukin-1 alpha and interleukin-6 secretion in human gingival cells.

Authors:  Yasukazu Saitoh; Nene Yonekura; Daigo Matsuoka; Akira Matsumoto
Journal:  Mol Cell Biochem       Date:  2021-09-17       Impact factor: 3.396

5.  [Protective effects of hydrogen-rich medium on lipopolysaccharides-induced injury in human periodontal ligament cells].

Authors:  Min Zhou; Zuo-Lin Wang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2018-04-01

6.  Hydrogen-Rich Saline Regulates Microglial Phagocytosis and Restores Behavioral Deficits Following Hypoxia-Ischemia Injury in Neonatal Mice via the Akt Pathway.

Authors:  Hongfei Ke; Dexiang Liu; Tingting Li; Xili Chu; Danqing Xin; Min Han; Shuanglian Wang; Zhen Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-21       Impact factor: 4.162

7.  Hydrogen therapy may be an effective and specific novel treatment for aplastic anemia.

Authors:  Liren Qian; Jianliang Shen; Jianming Cai
Journal:  Med Sci Monit       Date:  2012-06

Review 8.  Advances in the treatment of acute graft-versus-host disease.

Authors:  Liren Qian; Zhengcheng Wu; Jianliang Shen
Journal:  J Cell Mol Med       Date:  2013-06-26       Impact factor: 5.310

9.  Genotoxicity studies performed in the ecuadorian population.

Authors:  César Paz-Y-Miño; Nadia Cumbal; María Eugenia Sánchez
Journal:  Mol Biol Int       Date:  2012-02-16

10.  Effects of 7-day intake of hydrogen-rich water on physical performance of trained and untrained subjects.

Authors:  Rafael Timón; Guillermo Olcina; Adrian González-Custodio; Marta Camacho-Cardenosa; Alba Camacho-Cardenosa; Ismael Martínez Guardado
Journal:  Biol Sport       Date:  2020-10-22       Impact factor: 2.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.